Complete range of pharmaceutical research services.
Phase I bioequivalence studies of generic drugs. In-house clinical site and volunteer database. Planning, protocol, clinical operations, bioanalytics, and statistics.
Multi-center clinical trial management per ICH GCP, FDA, and EMA standards. Site selection and management, monitoring and auditing, CSR and final reporting.
In vitro and in vivo preclinical study management per GLP OECD standards. Toxicological, pharmacokinetic, and pharmacodynamic studies.
Treatment cost-effectiveness analysis. Markov modeling, budget impact analysis, and essential drug list dossier preparation.